Species-scale genomic analysis of S. aureus genes influencing phage host range and their relationships to virulence and antibiotic resistance genes
Abstract
Phage therapy has been proposed as a possible alternative treatment for infections caused by the ubiquitous bacterial pathogen Staphylococcus aureus. However, successful phage therapy requires knowing both host and phage genetic factors influencing host range for rational cocktail formulation. To further our understanding of host range, we searched 40,000+ public S. aureus genome sequences for previously identified phage resistance genes. We found that phage adsorption targets and genes that block phage assembly were significantly more conserved than genes targeting phage biosynthesis. Core phage resistance genes had similar nucleotide diversity, ratio of non-synonymous to synonymous substitutions, and functionality (measured by delta-bitscore) to other core genes in a set of 380 non-redundant S. aureus genomes (each from a different MLST sequence type). Non-core phage resistance genes were significantly less consistent with the core genome phylogeny than all non-core genes in this set. Only superinfection immunity genes correlated with empirically determined temperate phage resistance, accessory genome content, and numbers of accessory antibiotic resistance or virulence genes encoded per strain. Taken together, these results suggested that, while phage adsorption genes are heavily conserved in the S. aureus species, they are not undergoing positive selection, arms race dynamics. They also suggested genes classified as involved in assembly are least phylogenetically constrained and superinfection immunity genes best predict both empirical phage resistance and levels of phage-mediated HGT. ImportanceStaphylococcus aureus is a widespread, hospital- and community-acquired pathogen that is commonly antibiotic resistant. It causes diverse diseases affecting both the skin and internal organs. Its ubiquity, antibiotic resistance, and disease burden make new therapies urgent, such as phage therapy, in which viruses specific to infecting bacteria clear infection. S. aureus phage host range not only determines whether phage therapy will be successful by killing bacteria but also horizontal gene transfer through transduction of host genetic material by phages. In this work, we comprehensively reviewed existing literature to build a list of S. aureus phage resistance genes and searched our database of almost 43,000 S. aureus genomes for these genes to understand their patterns of evolution, finding that prophages superinfection immunity correlates best with phage resistance and HGT. These findings improved our understanding of the relationship between known phage resistance genes and phage host range in the species.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genes influencing phage host range in Staphylococcus aureus on a species-wide scale
A. G. Moller, K. Winston, … T. Read·bioRxiv·Jul 24, 2020
- Going through phages: A Computational approach to Revealing the role of prophage in Staphylococcus aureus
T. S. Sweet, S. Sindi, M. Sistrom·bioRxiv·Nov 10, 2021
- Phage resistance impacts antibiotic susceptibility and virulence in Staphylococcus aureus
Janine Zara Bowring, Freja Cecilie Mikkelsen, … Hanne Ingmer·bioRxiv·Sep 2, 2025
- Characterisation of bacteriophage JD419, a Staphylococcal phage with an unusual morphology and broad host range
T. Feng, S. Leptihn, … Z. Cui·bioRxiv·Nov 9, 2020
- Unraveling Resistance and Thresholds in Phage Therapy Using Staphylococcus aureus In Vitro Models
Kévin Royet, Leslie Blazere, … Sylvain Goutelle·bioRxiv·Apr 25, 2025
- Bacteriophage infection drives loss of β-lactam resistance in methicillin-resistant Staphylococcus aureus
My Tran, Angel J Hernandez Viera, … Charlie Y. Mo·eLifePeer-reviewed·Jul 10, 2025